• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters
• Other Chemical additives Functional Additives
• Other Chemical Reagents

Comprehensive Overview of (2S,3S)-2,3-Bis((4-methylbenzoyl)oxy)succinic acid hydrate (CAS No. 71607-32-4)

(2S,3S)-2,3-Bis((4-methylbenzoyl)oxy)succinic acid hydrate is a specialized organic compound with significant applications in pharmaceutical and chemical research. Its unique stereochemistry, marked by the (2S,3S) configuration, and the presence of 4-methylbenzoyl groups, makes it a valuable intermediate in the synthesis of chiral molecules. The compound's CAS No. 71607-32-4 serves as a critical identifier for researchers and regulatory bodies, ensuring precise communication in scientific literature and commercial transactions.

In recent years, the demand for chiral compounds like (2S,3S)-2,3-Bis((4-methylbenzoyl)oxy)succinic acid hydrate has surged due to their role in enantioselective synthesis. This trend aligns with the growing focus on green chemistry and sustainable pharmaceutical manufacturing, where minimizing waste and optimizing reaction efficiency are paramount. Researchers often search for "chiral building blocks" or "stereoselective synthesis" to find compounds like this, highlighting its relevance in modern organic chemistry.

The hydrate form of this compound adds another layer of utility, as it often improves solubility and stability—key factors in formulation development. Analytical techniques such as HPLC, NMR, and X-ray crystallography are typically employed to characterize its purity and confirm its stereochemical integrity. These methods are frequently queried in search engines by professionals seeking "how to analyze chiral compounds" or "techniques for verifying stereochemistry."

Beyond its synthetic applications, (2S,3S)-2,3-Bis((4-methylbenzoyl)oxy)succinic acid hydrate has garnered attention in drug discovery due to its potential as a scaffold for bioactive molecules. Its structural features, including the succinic acid core, are compatible with prodrug design, a hot topic in medicinal chemistry. Searches for "prodrug strategies" or "biodegradable linkers" often intersect with discussions about such compounds.

From a commercial perspective, suppliers and manufacturers emphasize the compound's high purity and batch consistency, addressing concerns raised in queries like "reliable sources for research chemicals." Regulatory compliance, particularly with REACH and GMP standards, is another critical aspect frequently searched by procurement specialists.

In summary, (2S,3S)-2,3-Bis((4-methylbenzoyl)oxy)succinic acid hydrate (CAS No. 71607-32-4) exemplifies the intersection of advanced organic synthesis and practical applications in pharmaceuticals. Its role in chiral technology, combined with its adaptability to sustainable chemistry principles, ensures its continued relevance in both academic and industrial settings.

• 62708-56-9((-)-Dibenzoyl-L-tartaric acid monohydrate)
• 71607-31-3(Di-p-toluoyl-D-tartaric Acid Monohydrate)
• 80822-15-7((+)-Dibenzoyl-D-Tartaric Acid Monohydrate)
• 918447-59-3(Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. withethyl acetate (1:1))
• 32634-68-7((+)-O,O’-Di-p-toluoyl-D-tartaric Acid)
• 32634-66-5((-)-Di-p-toluoyl-L-tartaric Acid)
• 2743-38-6(Di-O-benzoyl L-Tartaric Acid)
• 217968-14-4(Butanedioic acid,2,3-bis[(4-methylbenzoyl)oxy]-, ion(2-), (2S,3S)-)
• 80892-32-6(Dibenzoyl-D-tartaric acid)
• 87172-82-5((2R,3R)-2-(Benzoyloxy)-3-hydroxysuccinic acid)